Company Overview and News
The Boeing Co. (NYSE: BA) held on to its ranking as the top-performing stock among the Dow 30 last week, even though it ranked among the bottom five performers for the week. The company’s shares shed just over 3.1% in what was a good week for the index itself. For the year to date, Boeing shares have gained 21.4%.
V NKE BOE MSFT INTC BA
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
WCAGY V DB DBOEY DBOEF WRCDF
The tech sector has been hot for many months now, and was the first to break out of the S&P's correction in February.
STT.PRC TXN STT.PRE STT.PRD STT.PRG GOOG HTGZ ARKW FGB AMZN AMAT AAPL CSCO INTC FEO BIDU TSM IBM STT HUSV BOTZ FTEC FCM HDMV HTGX HTGY VGT BABA V GOOGL 0700 HTGC MSFT PSCT FOVCX
There’s nothing more thrilling than telling the tale of an incredible trade that dished out massive, short-term gains. Though most of these proverbial “whale hunts” don’t pan out as initially hoped, enough of them do to keep investors ever-searching for them.
ABT MTSI TXN NVDA KMB KCDMY ABT WMT V SWK KMB.WI JNJ MSFT ED INTC MMM
Visa, Inc. (NYSE:V) William Blair 2018 Growth Stock Conference Call June 13, 2018 1:00 PM ET
The 2018 FIFA World Cup in Russia kicks off Thursday on Fox (FOXA - Free Report) , with 32 nations set to compete in a 64-match tournament over the next month. Billions of people from over 200 countries are expected to watch, which means, for many, the stars are likely the main attraction. And there are few more well-known and revered athletes—or people—in the world than Lionel Messi. This means the Argentinian superstar makes a lot of money off the field, so let’s take a look at how to invest in one of soccer’s biggest stars.
FB V NKE PEP TWTR MA UTX
Starbucks Corporation (NASDAQ:SBUX) and Visa Inc (NYSE:V) have teamed up to roll out a prepaid card for customers who love their coffee but don’t want to limit themselves.
The 2018 FIFA World Cup in Russia kicks off Thursday on Fox (FOXA - Free Report) . The month-long tournament is expected to attract billions of viewers from over 200 countries, making it a marketing dream. The likes of Coca-Cola (KO - Free Report) , Visa (V - Free Report) , Budweiser (BUD - Free Report) , and McDonald’s (MCD - Free Report) will all be heavily featured, but Adidas (ADDYY - Free Report) and Nike (NKE - Free Report) are the only companies competing against each other.
UA V NKE CHJHF ADDYY UAA TWTR CHA 0728
Welcome to a 2018 FIFA World Cup episode of the Full-Court Finance podcast from Zacks Investment Research. This week, Ben Rains dives into everything that investors and casual fans need to know about the world’s biggest sporting event before it kicks off in Russia on Thursday.
UA V NKE CHJHF ADDYY UAA CHA 0728 BRKS
The 2018 FIFA World Cup kicks off this week in Russia. As 32 teams fight it out for the coveted trophy over a period of one month, FIFA will be banking on its sponsors for the much-needed stimulus after a poor financial showing for two consecutive years.
WFCNP ADDYY CCV MS.PRE WFC.PRL MS.PRF CCZ WFC.PRJ MS.PRG MS.PRA WFC.PRT WFC.PRR WFC.PRQ NKE AMZN WFC.PRP WFC.PRO WFC.PRN AAPL WFC.PRY MS WFC.PRX WFC.PRW CMCSK WFC.PRV WFC WFC.WS FOX BUD ADDDF CMCSA V MS.PRI CCV.CL MS.PRK AHBIF FOXA
Chicago, IL – June 11, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Adidas (ADDYY - Free Report) , Coca-Cola (KO - Free Report) , Visa (V - Free Report) , Budweiser (BUD - Free Report) and McDonald’s (MCD - Free Report) .
RYAM KBH HSC ADDYY WLK ALSN LB RYAM.PRA MCHP TRTN BGSF V MU SCVL CCK OXY MCD
Following a one-week absence, The Boeing Co. (NYSE: BA) has returned as the top-performing stock among the Dow 30 last week. Unlike its performance in 2017 when it grabbed the top ranking early and held it for most of the year, Boeing has bounced into and out of the top spot this year. The company’s shares added about 3.6% in what was a good week for the index itself. For the year to date, Boeing shares have gained 25.
V NKE BOE MSFT INTC BA
In September 2017, I received slightly over $100K as a result of the commuted value of my pension plan. I decided to invest 100% of this money into dividend growth stocks. Each month I publish my results. I don't do this to brag, I do this to show you it's possible to build a portfolio during an all-time high market. The market will crash… eventually. In the meantime, I rather cash out on some juicy dividends!
VIG ANCUF ANCTF ENB FTS CGC ENB TWMJF V ATD.A ATD.B FTS WEED
The 2018 FIFA World Cup in Russia is less than a week away, with the first game between the host country and Saudi Arabia scheduled to kick off at 11 a.m. ET on Thursday, June 14 on Fox (FOXA - Free Report) . Now that World Cup fever has started to truly set in, let’s take a look at how some of the biggest FIFA and World Cup sponsors have performed.
COF.PRG COF.PRH COF-P ADDYY CMCSA COF.WS MA COF.PRP COF SFIX COF-D COF-C COF-F V NKE COF.PRC OXY COF.PRD COF.PRF
2018-06-11 - Asif
Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...
2018-06-11 - Asif
Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...
2018-06-11 - Asif
Overview Stemline Therapeutics was incorporated under the laws of the State of Delaware in August 2003. Stemline Therapeutics is a clinical stage biopharmaceutical company focused on discovering, acquiring, developing and potentially commercializing innovative oncology therapeutics that target difficult to treat cancers. The company's clinical pipeline includes: SL-401, SL-801, and SL-701. SL-401 pivotal data; plans for registration and potential commercialization: SL-401 has completed a pivotal trial in patients with blastic plasmacytoid dendritic cell neoplasm, or BPDCN, and has successfully met the primary endpoint of the trial. SL-401 is a targeted therapy directed to the interleukin-3 receptor-a, or CD123. SL-401 was granted breakthrough therapy designation, or BTD, by the U.S. Food and Drug Administration, or FDA, for the treatment of patients with BPDCN. Based on the trial results and other data, the company expect to complete submission of a rolling Biologics License...
Silicon Investor Message Boards
This table lists all message boards related to V / Visa, Inc. on message board site Silicon Investor.
as of ET